Press release

Cision PR Newswire1 week ago
0

Foreign Experts: China’s Innovation Ecosystem to Benefit the World

BEIJING, Feb. 28, 2026 /PRNewswire/ — A report from Science and Technology Daily: As China’s 2026 Two Sessions approach, the global…
Read More »
Cision PR Newswire1 week ago
0

Navigara Launches the Performance Layer for Enterprise Engineering Teams and AI Tools Backed by $2.5M

The performance layer for modern engineering helps leaders prove whether AI tools actually improve performance and ROI SAN FRANCISCO, Feb.…
Read More »
Press Release

Cision PR Newswire1 week ago
0

MWC Barcelona 2026: YOFC to Unveil Hollow-Core Fibre (HCF) Solution, Advancing Optical Connectivity in the Era of AI

AI x Fibre: the company will highlight next-generation ultra-low latency optical communication technology, strengthening global AI infrastructure. BARCELONA, Spain, Feb.…
Read More »
Cision PR Newswire1 week ago
0

CGTN: How China’s path of democracy safeguards people’s rights and interests

Ahead of China’s annual key political meetings – the Two Sessions, CGTN published an article elaborating how China’s whole-process people’s…
Read More »
Cision PR Newswire1 week ago
0

Notice of Data Event

Centennial, Colorado – Pinnacle Holdings, LTD (“Pinnacle”) provides healthcare consulting services to certain healthcare organizations. Pinnacle experienced a data event…
Read More »
Press Release

Cision PR Newswire1 week ago
0

U.S. Food and Drug Administration Approves BioMarin’s PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)

Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS…
Read More »
Business Wire1 week ago

Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034

IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is…
Read More »
Business Wire1 week ago

Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034

IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is…
Read More »
Business Wire1 week ago

Secretary of War Pete Hegseth Visits L3Harris Solid Rocket Motor Site

CAMDEN, Ark.–(BUSINESS WIRE)–Secretary of War Pete Hegseth visited the L3Harris Technologies (NYSE: LHX) Camden site today as part of his…
Read More »
Cision PR Newswire1 week ago
0

Sunlight.com Survey: 1 in 5 Hiring Managers Admit They’re Less Likely To Hire Overweight Candidates

Weight bias shapes hiring, compensation, and promotion decisions KIRKLAND, Wash., Feb. 27, 2026 /PRNewswire/ — Weight discrimination in the workplace…
Read More »

Previous page Next page